We then characterized and validated the first cdkl5 mutant zebrafish line (sa21938) [26], suggesting its potential as a valuable model for exploring the underlying mechanisms of CDD and its relevance in high-throughput drug screening [27]. Here, CDKL5 is linked to craniodiaphyseal dysplasia.